Johnson & Johnson (Ethicon, Inc.), Baxter International, and Becton, Dickinson and Company are the leading players in the Surgical Sealants and Adhesives Market
The global surgical sealants and adhesives market is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period. Growth in this market is driven by the growing prevalence and incidence rates of various disorders such as obesity and CVDs; increasing incidence of trauma; and growth in the number of accidents and sports-related injuries, which has led to an increase in surgical procedures being performed across the globe. Also, the need to manage blood loss in patients and R&D being undertaken to bring innovative products to the market is aiding the market growth. Better cosmetic outcomes are also increasing their adoption in cosmetic procedures across the globe. Additionally, emerging markets provide significant investment opportunities for players as these regions offer an untapped potential due to the increasing government and private investments in the healthcare sector. The rising prominence of adhesive dentistry also offers significant growth opportunities for players operating in this space. However, the high cost of these products, lack of reimbursements, and high investments associated with clinical data requirements for these products are restraining the growth of this market to a certain extent. The market also faces the challenge of developing novel biomaterials for effective tissue sealing.
Johnson & Johnson (Ethicon, Inc.) (US), Baxter International, Inc. (US), Becton, Dickinson and Company (US), CryoLife, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia),and Ocular Therapeutix, Inc. (US) are the key players operating in this market. These companies are focusing on increasing their presence in high-growth markets through both organic and inorganic growth strategies such as product launches, acquisitions, and expansions.
To know about the assumptions considered for the study download the pdf brochure
Johnson & Johnson (Ethicon, Inc.) (US) was the leading player in the surgical sealants and adhesives market in 2019. The company has a strong brand value as well as an established geographic presence. It offers a strong and broad product portfolio for surgical sealants and adhesives, which serves as an important factor for its large market share. Its flagship sealants and hemostatic products such as EVICEL, SURGICEL, EVARREST, SURGIFLOW, and SURGIFOAM series are some of the leading brands in the global biosurgery market. The company has reported revenue growth of ~ 5-8% in its biosurgical products segment between 2018 and 2019. The growth of this segment is mainly driven by the company’s wide presence in the APAC market and continuous growth in the US market. It further focuses on increasing its presence in this market through continuous R&D activities to provide technologically advanced solutions to customers.
Baxter International, Inc. (US) is a leading provider of essential hospital and renal products & services. Baxter has been serving the medical device industry for over 80 years. The company has an exhaustive portfolio and seeks to strengthen it further through product launches and enhancements/upgrades. Baxter offers a comprehensive portfolio of surgical sealants and adhesives across the globe. The companys strong focus on R&D activities has helped it in building a strong portfolio of innovative products. Baxter’s acquisition of Synovis Life Technologies, Inc. (US) has further enabled the firm to offer collaborative products for the surgical sealants and adhesives market. The company further seeks to strengthen its product offerings through product enhancements and by expanding its advanced surgery product portfolio, which includes FLOSEAL Hemostatic Matrix and TISSEEL through product acquisitions in April 2017. The company’s emphasis on such strategies offers significant opportunities for expansion in this industry.
Related Reports:
Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User - Global Forecast to 2025
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
